Literature DB >> 11207875

Suboptimal prescribing in older inpatients and outpatients.

J T Hanlon1, K E Schmader, C M Ruby, M Weinberger.   

Abstract

Investigators searched Medline and HealthSTAR databases from January 1, 1985 through June 30, 1999 to identify articles on suboptimal prescribing in those age 65 years and older. A manual search of the reference lists from identified articles and the authors' article files, book chapters, and recent reviews was conducted to identify additional articles. The definitions for various types of suboptimal prescribing (polypharmacy, inappropriate, and underutilization) are numerous, and measurement varies from study to study. The literature suggests that suboptimal prescribing is common in older outpatients and inpatients. Moreover, there is significant morbidity and mortality associated with suboptimal prescribing for these older patients. Evidence from well-controlled studies suggests that multidisciplinary teams and clinical pharmacy interventions can modify suboptimal drug use in older people. Future research is necessary to measure and test other methods for tackling this major public health problem facing older people.

Entities:  

Mesh:

Year:  2001        PMID: 11207875     DOI: 10.1046/j.1532-5415.2001.49042.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  125 in total

1.  Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study.

Authors:  S Ruths; J Straand; H A Nygaard
Journal:  Qual Saf Health Care       Date:  2003-06

2.  Potentially inappropriate medications and risk of hospitalization in retirees: analysis of a US retiree health claims database.

Authors:  Steven M Albert; Alberto Colombi; Joseph Hanlon
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

3.  Guideline interaction: a study of interactions among drug-disease contraindication rules.

Authors:  Te Hui Kuo; Eneida A Mendonca; Jianrong Li; Yves A Lussier
Journal:  AMIA Annu Symp Proc       Date:  2003

Review 4.  Polypharmacy in older adults with cancer.

Authors:  Ronald J Maggiore; Cary P Gross; Arti Hurria
Journal:  Oncologist       Date:  2010-04-24

5.  Use of proton-pump inhibitors and their associated risks among frail elderly nursing home residents.

Authors:  Mariko Teramura-Grönblad; Helka Hosia-Randell; Seija Muurinen; Kaisu Pitkala
Journal:  Scand J Prim Health Care       Date:  2010-09       Impact factor: 2.581

6.  Reduction of inappropriate medications among older nursing-home residents: a nurse-led, pre/post-design, intervention study.

Authors:  Eva Blozik; Andreas M Born; Andreas E Stuck; Ulrich Benninger; Gerhard Gillmann; Kerri M Clough-Gorr
Journal:  Drugs Aging       Date:  2010-12-01       Impact factor: 3.923

Review 7.  Underprescription of beneficial medicines in older people: causes, consequences and prevention.

Authors:  Antonio Cherubini; Andrea Corsonello; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

8.  Usually Available Clinical and Laboratory Data Are Insufficient for a Valid Medication Review: A Crossover Study.

Authors:  K P G M Hurkens; C Mestres-Gonzalvo; H A J M de Wit; P H M van der Kuy; R Janknegt; F Verhey; J M G A Schols; C D A Stehouwer; B Winkens; W Mulder
Journal:  J Nutr Health Aging       Date:  2016-01       Impact factor: 4.075

9.  Associations between drug burden index and mortality in older people in residential aged care facilities.

Authors:  Nicholas M Wilson; Sarah N Hilmer; Lyn M March; Jian Sheng Chen; Danijela Gnjidic; Rebecca S Mason; Ian D Cameron; Philip N Sambrook
Journal:  Drugs Aging       Date:  2012-02-01       Impact factor: 3.923

Review 10.  The relationship between the extent of collaboration of general practitioners and pharmacists and the implementation of recommendations arising from medication review: a systematic review.

Authors:  Henk-Frans Kwint; Lynette Bermingham; Adrianne Faber; Jacobijn Gussekloo; Marcel L Bouvy
Journal:  Drugs Aging       Date:  2013-02       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.